GEORGE J MORROW
CIK 1068754 · Exe VP, Global Commercial Ops · last filed 2026-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$50.92M
Companies
7
Total Filings
89
Lifetime Open-Market Net
-$44.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NBIX | Director | 10,386 | $159.76 | $1.66M | -$7.73M | 16 | 2026-05-29 |
| ALGN | Director | 8,309 | $174.84 | $1.45M | -$32.74M | 30 | 2026-05-22 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Director | 27,347 | — | — | $123 | 6 | 2018-05-24 |
| OTONOMY, INC. (OTIC) Delisted | Director | — | $0.08 | — | $0 | 3 | 2017-07-14 |
| SAFEWAY INC (SWY) Delisted | Director | — | — | — | $0 | 14 | 2015-02-02 |
| HUMAN GENOME SCIENCES INC (HGSI) Delisted | Director | 0 | — | — | $157.9K | 5 | 2012-08-01 |
| AMGN | Exe VP, Global Commercial Ops | 134,606 | $355.20 | $47.81M | -$4.06M | 15 | 2010-04-30 |
Recent Filings · Page 4 of 9
89 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-07-14 | OTONOMY, INC. (OTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-08 | NBIX | Grant (A) | — | $0 | EDGAR |
| 2017-05-30 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-18 | ALGN | Mixed | +5,000 | $0 | EDGAR |
| 2016-06-21 | OTONOMY, INC. (OTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-24 | ALGN | Mixed | — | -$3.01M | EDGAR |
| 2016-05-24 | NBIX | Grant (A) | — | $0 | EDGAR |
| 2016-05-24 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-19 | ALGN | Grant (A) | — | $0 | EDGAR |
| 2016-05-16 | ALGN | Exer (M) | +5,500 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.